Good morning and welcome to the Week Ahead at the start of a slightly quieter (and hopefully less bruising) week for private investors.

The first cut in interest rate from the Bank of England since 2020 (to 5% on Thursday) wasn’t enough to ease international investors’ concerns about the state of the US economy. Last week we saw disappointing jobs data, which sparked mutterings that the US Federal Reserve has left it too late to cut interest rates. As earnings season starts to come to an end, investors have started selling.

The S&P500 closed the week down more than 2%, with the FTSE All Share down 1.5%.

There is still a strong handful of financial results on both sides of the pond to take a look at this morning (see table for the full calendar). The pharmaceutical sector (always a hot industry in election year) has a few companies announcing numbers, which Megan will look at later. But for now, we’ve taken a look at two British companies which have been on a strong run.

Day

UK interim results

US quarterly results

EU quarterly results

Monday - 5th August

Tyson Foods
CSX

Infineon Technologies

Tuesday - 6th August

InterContinental Hotels Group
Travis Perkins
Rotork
SIG

Amgen
Caterpillar
Teradata
Molson Coors Brewing

Zalando
Bayer
Adecco

Wednesday - 7th August

Ibstock
Glencore
CLS
Hiscox


CVS Health
Walt Disney
Ralph Lauren
Occidental Petroleum
Monster Beverage
Zimmer

Siemens
Beiersdorf
Puma
Novo Nordisk

Thursday - 8th August

Persimmon
Beazley
Hikma Pharmaceuticals
Lancashire Holdings
CRH

Eli Lilly & Co
Gilead Sciences
Murphy Oil

Allianz
Deutsche Telekom
Zurich Insurance Group

Friday - 9th August

Bellway
Hargreaves Lansdown


Bechtle



Persimmon - On the road to recovery?

A few of the UK’s largest housebuilders will be providing updates next week. Roland Head recently wrote an excellent piece on the UK housing sector backdrop and what might come next for the housebuilders here. The article assesses the financial health and outlook of major UK housebuilders, noting that despite past profit surges, current valuations might still offer investment opportunities, especially if the sector's conditions improve as anticipated.

For now, however, we will focus…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here